Search Results 1271-1280 of 15402 for Hepatitis b

  1. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...

  2. cirrhosis Archives - Mayo Clinic News Network

    drinking can cause hepatic steatosis, or increased fat in the liver, and alcoholic hepatitis, or inflammation of the liver. Over time, heavy drinking can ...

  3. Tofacitinib (oral route) - Side effects & dosage - Mayo Clinic

    Lymphopenia (blood disease)—Use with caution. May increase risk of developing infections. Heart or blood vessel disease or; Hepatitis B, history of or ...

  4. Fatty liver disease (MASLD) - Doctors and departments - Mayo Clinic

    ... Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease..., Portal hypertension, Ascites, Alcoholic hepatitis. Show more areas of focus for Hugo E. Vargas ...

  5. Omar Y. Mousa, M.B.B.S., M.D.

    He is fluent in Arabic and English, and conversant in Spanish. Conditions treated · Acute liver failure · Alcoholic hepatitis · Autoimmune hepatitis ...

  6. A Study to Evaluate HKI-272 and Capecitabine for HER2-Positive Breast Cancer and Brain Metastases - Mayo Clinic

    ... B or hepatitis C with abnormal liver function tests (Cohorts 4A-4C):. Positive Hepatitis B (Hepatitis B surface antigen and antibody) and/or Hepatitis C ( ...

  7. Liver cancer - Doctors and departments - Mayo Clinic

    ... Hepatitis C, Hepatitis B, Primary biliary cholangitis, Pr...imary sclerosing cholangitis, Wilson's disease, Portal hypertension, Autoimmune hepatitis ...

  8. Phase I Study Of BL0020, A Novel Anti-tumor Drug, In Adult Subjects With Advanced Solid Tumors - Mayo Clinic

    ... hepatitis B at screening). In addition, eligible hepatitis B or hepatitis C patients must agree to antiviral treatment according to the treatment guidelines.

  9. A Study To Evaluate The Safety And Effectiveness Of AMG 592 In Subjects With Steroid Refractory Chronic Graft Versus Host Disease - Mayo Clinic

    Subject is positive for hepatitis B surface antigen, hepatitis B core antibody (confirmed by hepatitis B deoxyribonucleic acid [DNA] polymerase chain ...

  10. Tocilizumab-bavi (intravenous route) - Side effects & uses - Mayo Clinic

    Infections (eg, hepatitis B, bacteria, virus, fungus), active or recurring or; Liver disease, active—Should not be used in patients with these conditions ...